CH615660A5 - Esterification process - Google Patents

Esterification process Download PDF

Info

Publication number
CH615660A5
CH615660A5 CH632178A CH1368777A CH615660A5 CH 615660 A5 CH615660 A5 CH 615660A5 CH 632178 A CH632178 A CH 632178A CH 1368777 A CH1368777 A CH 1368777A CH 615660 A5 CH615660 A5 CH 615660A5
Authority
CH
Switzerland
Prior art keywords
benzotriazole
substituted
group
chloro
mixture
Prior art date
Application number
CH632178A
Other languages
German (de)
English (en)
Inventor
Masumi Itoh
Jiyoji Notani
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of CH615660A5 publication Critical patent/CH615660A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/08Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18Benzotriazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/10General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using coupling agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
CH632178A 1974-03-04 1974-04-26 Esterification process CH615660A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2586674A JPS5748534B2 (enrdf_load_stackoverflow) 1974-03-04 1974-03-04

Publications (1)

Publication Number Publication Date
CH615660A5 true CH615660A5 (en) 1980-02-15

Family

ID=12177709

Family Applications (1)

Application Number Title Priority Date Filing Date
CH632178A CH615660A5 (en) 1974-03-04 1974-04-26 Esterification process

Country Status (2)

Country Link
JP (1) JPS5748534B2 (enrdf_load_stackoverflow)
CH (1) CH615660A5 (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002072564A1 (fr) * 2001-03-12 2002-09-19 Ono Pharmaceutical Co., Ltd. Compose de n-phenylarylsulfonamide, medicament contenant le compose en tant que principe actif, intermediaire pour le compose et ses procedes de production

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002072564A1 (fr) * 2001-03-12 2002-09-19 Ono Pharmaceutical Co., Ltd. Compose de n-phenylarylsulfonamide, medicament contenant le compose en tant que principe actif, intermediaire pour le compose et ses procedes de production
EP1612208A3 (en) * 2001-03-12 2006-12-06 Ono Pharmaceutical Co., Ltd. N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
RU2299202C2 (ru) * 2001-03-12 2007-05-20 Оно Фармасьютикал Ко., Лтд. N-фениларилсульфонамид, фармацевтическая композиция, содержащая указанное соединение в качестве активного ингредиента, соединение, являющееся промежуточным в синтезе указанного соединения, и способ его получения
US7235667B2 (en) 2001-03-12 2007-06-26 Ono Pharmaceutical Co., Ltd. N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
US7629369B2 (en) 2001-03-12 2009-12-08 Ono Pharmaceuticals Co., Ltd. N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
US8088802B2 (en) 2001-03-12 2012-01-03 Ono Pharmaceutical Co., Ltd. N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
CZ304035B6 (cs) * 2001-03-12 2013-08-28 Ono Pharmaceutical Co., Ltd. N-fenylarylsulfonamidová sloucenina, farmaceutická kompozice obsahující tuto slouceninu jako úcinnou slozku, syntetický meziprodukt pro tuto slouceninu a zpusob jeho prípravy

Also Published As

Publication number Publication date
JPS5748534B2 (enrdf_load_stackoverflow) 1982-10-16
JPS50117711A (enrdf_load_stackoverflow) 1975-09-16

Similar Documents

Publication Publication Date Title
SU1205764A3 (ru) Способ получени производных тризамещенных имидазолов или их солей
CH643558A5 (de) Cephemderivate und verfahren zu ihrer herstellung.
EP0001113A1 (de) Thienothiazinderivate, deren Herstellung, sowie diese enthaltende Präparate
DE2848912C2 (enrdf_load_stackoverflow)
US4242507A (en) Sulfonic acid esters
EP0096297B1 (de) Verfahren zur Herstellung von 1-Sulfo-2-oxoazetidinderivaten
DE2552403C2 (de) Thieno[1,5]-benzodiazepine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
DE2434340A1 (de) 7-acylamido-3-cephem-4-carbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen zubereitungen
DE2166467A1 (de) Neue penicillansaeurederivate, deren herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen
DE602004008300T2 (de) Thiazolinderivate als selektive androgenrezeptormodulatoren (sarms)
DE3407505A1 (de) Neue benzothiazin-carbonsaeureamide mit antiarthritischer wirksamkeit
DE1122541B (de) Verfahren zur Herstellung von Sulfamyl-anthranilsaeuren
EP0008652A1 (de) Neue Zwischenprodukte und deren Verwendung zur Herstellung von neuen Oxadiazolopyrimidinderivaten
EP0107622B1 (de) Neue Benzodioxolderivate, Verfahren zu deren Herstellung und entsprechende pharmazeutische Zusammensetzungen
CH615660A5 (en) Esterification process
DD243024A5 (de) Verfahren zur herstellung neuer 3-phenyl-2-propenamin-derivate
DE2724073A1 (de) 3,7-disubstituierte 3-cephem-4- carbonsaeuren und sie enthaltende pharmazeutische zubereitungen
DE2534926A1 (de) Sauerstoffanaloge von cephalosporinen
DD232045A5 (de) Verfahren zur herstellung von vorwirkstoffen entzuendungshemmender oxicame
DE3017977A1 (de) Neue substituierte 2(3h)-benzothiazolone
DE1695812A1 (de) Neue Derivate von c,f-Dibenzo-1,2-thiazepin und Verfahren zu ihrer Herstellung
EP0011092A1 (de) Alpha-Aminophenylessigsäurederivate zur Verwendung bei der Behandlung von Entzündungen sowie neue alpha-Aminophenylessigsäurederivate
DE2903909A1 (de) 7-(2,3-dihydrobenzo-5-furanyl)- acetamido-cephalosporinderivate und verfahren zu deren herstellung
DE3878700T2 (de) Verfahren zur herstellung von thiazolobenzimidazolen und zwischenprodukte.
DE3116891A1 (de) Steroid-oxazole

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased